Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study

AstraZeneca

Status: Completed

Conditions: GERD

Study type: Observational

Funder types: Industry

Identifiers

NCT00697008

NIS-GES-DUM-2007/3

Details and patient eligibility

About

To evaluate symptomatic outcome and HRQoL in GERD patients treated following a new CP Guideline.

Enrollment: 300 estimated patients

Sex: All

Ages: 17+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed informed consent
• Age above 18
• Subjects with typical GERD symptoms: predominant heartburn/regurgitation
• Naive patients or off PPI treatment in the last 2 months

Exclusion criteria

• Inability to read and understand PRO instructions
• Patient not suitable to be treated following the AEG guidelines
• Concomitant treatment with NSAID, antiplatelet drugs
• Previous PPI failure

Trial design

300 participants in 1 patient group

GERD patients

Description:

Patients with typical GERD symptoms